The "on-off" response to chronic L-DOPA treatment of Parkinsonism.
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D003221:Confusion / Q000139:chemically induced; D004044:Dietary Proteins / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D005684:Gait; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D009069:Movement Disorders / Q000139:chemically induced* / Q000178:diet therapy / Q000517:prevention & control; D009120:Muscle Cramp / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004044:Dietary Proteins; D004791:Enzyme Inhibitors; D007980:Levodopa; D008750:Methyldopa